- Filed
- Feb 11, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Jan 31, 2026 | 24.61M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 25.92M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2025 | 25.96M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 25.54M sh |
| Shares Diluted | Q3 2026 · Dec 31, 2024 | 25.64M sh |
| Capex | Q3 2026 · Dec 31, 2025 | $15.78M |
| Capex | Q3 2026 · Dec 31, 2024 | $15.12M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2025 | −$518.57M |
| Operating Cash Flow | Q3 2026 · Dec 31, 2024 | −$171.69M |
| Long Term Debt | Q3 2026 · Dec 31, 2025 | $455.53M |
| Long Term Debt | Q3 2026 · Mar 31, 2025 | $454.85M |
| Long Term Debt | Q3 2026 · Dec 31, 2024 | $454.64M |
| Short Term Debt | Q3 2026 · Dec 31, 2025 | $833.73M |
| Short Term Debt | Q3 2026 · Mar 31, 2025 | $395.03M |
| Short Term Debt | Q3 2026 · Dec 31, 2024 | $608.65M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2025 | $129.84M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2025 | $78.25M |
| Cash And Equivalents | Q3 2026 · Dec 31, 2024 | $103.34M |
| Cash And Equivalents | Q3 2026 · Mar 31, 2024 | $92.57M |
| Stockholders Equity | Q3 2026 · Dec 31, 2025 | $161.25M |
| Stockholders Equity | Q3 2026 · Mar 31, 2025 | $160.09M |
| Stockholders Equity | Q3 2026 · Dec 31, 2024 | $161.92M |
| Current Liabilities | Q3 2026 · Dec 31, 2025 | $1.18B |
| Current Liabilities | Q3 2026 · Mar 31, 2025 | $773.95M |
| Current Liabilities | Q3 2026 · Dec 31, 2024 | $999.83M |
| Total Liabilities | Q3 2026 · Dec 31, 2025 | $1.75B |
| Total Liabilities | Q3 2026 · Mar 31, 2025 | $1.34B |
| Total Liabilities | Q3 2026 · Dec 31, 2024 | $1.55B |
| Current Assets | Q3 2026 · Dec 31, 2025 | $1.57B |
| Current Assets | Q3 2026 · Mar 31, 2025 | $1.16B |
| Current Assets | Q3 2026 · Dec 31, 2024 | $1.39B |
| Total Assets | Q3 2026 · Dec 31, 2025 | $1.92B |
| Total Assets | Q3 2026 · Mar 31, 2025 | $1.5B |
| Total Assets | Q3 2026 · Dec 31, 2024 | $1.72B |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | $0.65 |
| Eps Diluted | Q3 2026 · Dec 31, 2025 | $0.01 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | $0.74 |
| Eps Diluted | Q3 2026 · Dec 31, 2024 | $0.79 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | $0.65 |
| Eps Basic | Q3 2026 · Dec 31, 2025 | $0.01 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | $0.74 |
| Eps Basic | Q3 2026 · Dec 31, 2024 | $0.79 |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $38.28M |
| Sga Expense | Q3 2026 · Dec 31, 2025 | $118.8M |
| Sga Expense | Q3 2026 · Dec 31, 2024 | $46.51M |
| Sga Expense | Q3 2026 · Dec 31, 2024 | $126.05M |
| Net Income | Q3 2026 · Dec 31, 2025 | $16.9M |
| Net Income | Q3 2026 · Dec 31, 2025 | $199K |
| Net Income | Q3 2026 · Dec 31, 2024 | $18.9M |
| Net Income | Q3 2026 · Dec 31, 2024 | $20.31M |
| Operating Income | Q3 2026 · Dec 31, 2025 | $51.29M |
| Operating Income | Q3 2026 · Dec 31, 2025 | $119.01M |
| Operating Income | Q3 2026 · Dec 31, 2024 | $66.08M |
| Operating Income | Q3 2026 · Dec 31, 2024 | $139.62M |
| Gross Profit | Q3 2026 · Dec 31, 2025 | $99.89M |
| Gross Profit | Q3 2026 · Dec 31, 2025 | $253.31M |
| Gross Profit | Q3 2026 · Dec 31, 2024 | $116.45M |
| Gross Profit | Q3 2026 · Dec 31, 2024 | $275.77M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $555.91M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2025 | $1.48B |
| Cost Of Revenue | Q3 2026 · Dec 31, 2024 | $661.86M |
| Cost Of Revenue | Q3 2026 · Dec 31, 2024 | $1.7B |